268 related articles for article (PubMed ID: 16735998)
1. HIF-1 and tumour radiosensitivity.
Moeller BJ; Dewhirst MW
Br J Cancer; 2006 Jul; 95(1):1-5. PubMed ID: 16735998
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia and radiotherapy: opportunities for improved outcomes in cancer treatment.
Moeller BJ; Richardson RA; Dewhirst MW
Cancer Metastasis Rev; 2007 Jun; 26(2):241-8. PubMed ID: 17440683
[TBL] [Abstract][Full Text] [Related]
3. [Hypoxia and angiogenesis].
Simon JM
Bull Cancer; 2007 Jul; 94 Spec No():S160-5. PubMed ID: 17846000
[TBL] [Abstract][Full Text] [Related]
4. Pleiotropic effects of HIF-1 blockade on tumor radiosensitivity.
Moeller BJ; Dreher MR; Rabbani ZN; Schroeder T; Cao Y; Li CY; Dewhirst MW
Cancer Cell; 2005 Aug; 8(2):99-110. PubMed ID: 16098463
[TBL] [Abstract][Full Text] [Related]
5. The role of the hypoxia-inducible factor in tumor metabolism growth and invasion.
Brahimi-Horn C; Pouysségur J
Bull Cancer; 2006 Aug; 93(8):E73-80. PubMed ID: 16935775
[TBL] [Abstract][Full Text] [Related]
6. The HIF pathway in cancer.
Maxwell PH
Semin Cell Dev Biol; 2005; 16(4-5):523-30. PubMed ID: 16144689
[TBL] [Abstract][Full Text] [Related]
7. Reactive oxygen species and HIF-1 signalling in cancer.
Galanis A; Pappa A; Giannakakis A; Lanitis E; Dangaj D; Sandaltzopoulos R
Cancer Lett; 2008 Jul; 266(1):12-20. PubMed ID: 18378391
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-induced autophagy reduces radiosensitivity by the HIF-1α/miR-210/Bcl-2 pathway in colon cancer cells.
Sun Y; Xing X; Liu Q; Wang Z; Xin Y; Zhang P; Hu C; Liu Y
Int J Oncol; 2015 Feb; 46(2):750-6. PubMed ID: 25385144
[TBL] [Abstract][Full Text] [Related]
9. Treatment regimen determines whether an HIF-1 inhibitor enhances or inhibits the effect of radiation therapy.
Harada H; Itasaka S; Zhu Y; Zeng L; Xie X; Morinibu A; Shinomiya K; Hiraoka M
Br J Cancer; 2009 Mar; 100(5):747-57. PubMed ID: 19223896
[TBL] [Abstract][Full Text] [Related]
10. Cancer cells that survive radiation therapy acquire HIF-1 activity and translocate towards tumour blood vessels.
Harada H; Inoue M; Itasaka S; Hirota K; Morinibu A; Shinomiya K; Zeng L; Ou G; Zhu Y; Yoshimura M; McKenna WG; Muschel RJ; Hiraoka M
Nat Commun; 2012 Apr; 3():783. PubMed ID: 22510688
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-inducible factor-1, a new possible important factor in neoplasia.
Rekwirowicz H; Marszałek A
Pol J Pathol; 2009; 60(2):61-6. PubMed ID: 19886179
[TBL] [Abstract][Full Text] [Related]
12. The HIF-1-active microenvironment: an environmental target for cancer therapy.
Kizaka-Kondoh S; Tanaka S; Harada H; Hiraoka M
Adv Drug Deliv Rev; 2009 Jul; 61(7-8):623-32. PubMed ID: 19409433
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia sustains glioblastoma radioresistance through ERKs/DNA-PKcs/HIF-1α functional interplay.
Marampon F; Gravina GL; Zani BM; Popov VM; Fratticci A; Cerasani M; Di Genova D; Mancini M; Ciccarelli C; Ficorella C; Di Cesare E; Festuccia C
Int J Oncol; 2014 Jun; 44(6):2121-31. PubMed ID: 24676782
[TBL] [Abstract][Full Text] [Related]
14. Raising the bar: how HIF-1 helps determine tumor radiosensitivity.
Moeller BJ; Dewhirst MW
Cell Cycle; 2004 Sep; 3(9):1107-10. PubMed ID: 15326390
[TBL] [Abstract][Full Text] [Related]
15. Cell-permeable hypoxia-inducible factor-1 (HIF-1) antagonists function as tumor radiosensitizers.
Shi M; Guo XT; Shu MG; Chen FL; Li LW
Med Hypotheses; 2007; 69(1):33-5. PubMed ID: 17280792
[TBL] [Abstract][Full Text] [Related]
16. Silencing of osteopontin promotes the radiosensitivity of breast cancer cells by reducing the expression of hypoxia inducible factor 1 and vascular endothelial growth factor.
Yang L; Zhao W; Zuo WS; Wei L; Song XR; Wang XW; Zheng G; Zheng MZ
Chin Med J (Engl); 2012 Jan; 125(2):293-9. PubMed ID: 22340562
[TBL] [Abstract][Full Text] [Related]
17. ATR controls cellular adaptation to hypoxia through positive regulation of hypoxia-inducible factor 1 (HIF-1) expression.
Fallone F; Britton S; Nieto L; Salles B; Muller C
Oncogene; 2013 Sep; 32(37):4387-96. PubMed ID: 23085754
[TBL] [Abstract][Full Text] [Related]
18. HIF-1 and NDRG2 contribute to hypoxia-induced radioresistance of cervical cancer Hela cells.
Liu J; Zhang J; Wang X; Li Y; Chen Y; Li K; Zhang J; Yao L; Guo G
Exp Cell Res; 2010 Jul; 316(12):1985-93. PubMed ID: 20206160
[TBL] [Abstract][Full Text] [Related]
19. Targeting hypoxia, HIF-1, and tumor glucose metabolism to improve radiotherapy efficacy.
Meijer TW; Kaanders JH; Span PN; Bussink J
Clin Cancer Res; 2012 Oct; 18(20):5585-94. PubMed ID: 23071360
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-inducible factor-1α downregulation by small interfering RNA inhibits proliferation, induces apoptosis, and enhances radiosensitivity in chemical hypoxic human hepatoma SMMC-7721 cells.
Yang W; Sun T; Cao J; Fan S
Cancer Biother Radiopharm; 2011 Oct; 26(5):565-71. PubMed ID: 21950556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
